The emerging approach of the medication represents a major advance in the handling of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatide-peptide157233.articlesblogger.com/64431278/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment